Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare136. Raveh L, Weissman BA, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Brandeis R. Caramiphen and scopolamine preventsoman-induced brain damage and cognitive dysfunction. Neurotoxicol. 2002;23:7–17.137. Raveh L, Brandeis R, Gilat E, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Weissman BA. Anticholinergic and antiglutamatergicagents protect against soman-induced brain damage and cognitive dysfunction. Toxicol Sci. 2003;75:108–116.138. Raffaele K, Hughey D, Wenk G, Olton D, Modrow H, McDonough J. Long-term behavioral changes in rats followingorganophosphonate exposure. Pharmacol Biochem Behav. 1987;27:407–412.139. McDonough JH Jr, Smith RF, Smith CD. Behavioral correlates of soman-induced neuropathology: deficits in DRLacquisition. Neurobehav Toxicol Teratol. 1986;8:179–187.140. Modrow HE, Jaax NK. Effect of soman exposure on the acquisition of an operant alternation task. Pharmacol BiochemBehav. 1989;32:49–53.141. Shorvon SD. Status Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge, England: CambridgeUniversity Press; 1994: 195–213.142. Nozaki H, Aikawa N, Fujishima S, et al. A case of VX poisoning and the difference from sarin. Lancet. 1995;346:698–699.143. Himuro K, Murayama S, Nishiyama K, et al. Distal sensory axonopathy after sarin intoxication. Neurology. 1998;51:1195–1197.144. Christensen MK, Cresthull P, Crook JW, Oberst FW, Ross RS, Umland CW 2nd. Resuscitation of dogs poisoned byinhalation of the nerve gas GB. Mil Med. 1956;119:377–386.145. Pazdernik TL, Cross RS, Giesler M, Samson FE, Nelson SR. Changes in local cerebral glucose utilization induced byconvulsants. Neuroscience. 1985;14:823–835.146. Kiss Z, Fazekas T. Arrhythmias in organophosphate poisoning. Acta Cardiol. 1979;34:323–330.147. Hassler CR, Moutvic RR, Hamlin RL. Studies of the action of chemical agents on the heart. In: Proceedings of the SixthMedical Chemical Defense Bioscience Review. Aberdeen Proving Ground, Md: US Army Medical Research Institute forChemical Defense; 1987: 551–554.148. Hassler CR, Moutvic RR, Hobson DW, et al. Long-term arrhythmia analysis of primates pretreated with pyridostigmine,challenged with soman, and treated with atropine and 2-PAM. In: Proceedings of the 1989 Medical Chemical DefenseBioscience Review. Aberdeen Proving Ground, Md: US Army Medical Research Institute for Chemical Defense; 1989:479–482.149. Ludomirsky A, Klein HO, Sarelli P, et al. Q-T prolongation and polymorphous (“torsade de pointes”) ventricular arrhythmiasassociated with organophosphorus insecticide poisoning. Am J Cardiol. 1982;49:1654–1658.150. Allon N, Rabinovitz I, Manistersky E, Weissman BA, Grauer E. Acute and long-lasting cardiac changes following asingle whole-body exposure to sarin vapor in rats. Toxicol Sci. 2005; 87:385–390.151. Singer AW, Jaax NK, Graham JS, McLeod CG Jr. Cardiomyopathy in soman and sarin intoxicated rats. Toxicol Lett.1987;36:243–249.152. Baze WB. Soman-induced morphological changes: an overview in the non-human primate. J Appl Toxicol. 1993;13:173–177.153. Britt JO Jr, Martin JL, Okerberg CV, Dick EJ Jr. Histopathologic changes in the brain, heart, and skeletal muscle of rhesusmacaques, ten days after exposure to soman (an organophosphorus nerve agent). Comp Med. 2000;50:133–139.212